Correlation Between Aerovate Therapeutics and 126408GW7
Specify exactly 2 symbols:
By analyzing existing cross correlation between Aerovate Therapeutics and CSX P 475, you can compare the effects of market volatilities on Aerovate Therapeutics and 126408GW7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 126408GW7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 126408GW7.
Diversification Opportunities for Aerovate Therapeutics and 126408GW7
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aerovate and 126408GW7 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and CSX P 475 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSX P 475 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 126408GW7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSX P 475 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 126408GW7 go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and 126408GW7
If you would invest 208.00 in Aerovate Therapeutics on October 7, 2024 and sell it today you would earn a total of 60.00 from holding Aerovate Therapeutics or generate 28.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Aerovate Therapeutics vs. CSX P 475
Performance |
Timeline |
Aerovate Therapeutics |
CSX P 475 |
Aerovate Therapeutics and 126408GW7 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and 126408GW7
The main advantage of trading using opposite Aerovate Therapeutics and 126408GW7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 126408GW7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 126408GW7 will offset losses from the drop in 126408GW7's long position.Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
126408GW7 vs. Small Cap Premium | 126408GW7 vs. Black Spade Acquisition | 126408GW7 vs. MGIC Investment Corp | 126408GW7 vs. Triton International Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |